Boule Diagnostics AB (publ) (STO: BOUL)
Sweden
· Delayed Price · Currency is SEK 6.78
+0.04 (0.59%)
Nov 19, 2024, 4:29 PM CET
Boule Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 563.33 | 571.33 | 548.09 | 463.34 | 400.46 | 498.92 | Upgrade
|
| Revenue Growth (YoY) | -1.58% | 4.24% | 18.29% | 15.70% | -19.73% | 17.56% | Upgrade
|
| Cost of Revenue | 309.02 | 321.62 | 320.18 | 264.71 | 223.27 | 272.71 | Upgrade
|
| Gross Profit | 254.31 | 249.71 | 227.91 | 198.64 | 177.19 | 226.21 | Upgrade
|
| Selling, General & Admin | 164.45 | 153.35 | 143.6 | 120.15 | 110.94 | 128.11 | Upgrade
|
| Research & Development | 310.29 | 53.09 | 51.57 | 43.33 | 43.05 | 29.94 | Upgrade
|
| Other Operating Expenses | -0.23 | -0.23 | -0.74 | -0.7 | -0.79 | -1.64 | Upgrade
|
| Operating Expenses | 474.51 | 206.21 | 194.43 | 162.78 | 153.19 | 156.41 | Upgrade
|
| Operating Income | -220.2 | 43.5 | 33.48 | 35.86 | 24 | 69.8 | Upgrade
|
| Interest Expense | -11.5 | -11.3 | -9.85 | -5.49 | -4.21 | -5.85 | Upgrade
|
| Interest & Investment Income | 1.54 | 1.14 | 1.78 | 1.35 | 0.31 | 1.79 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -40.28 | -15.18 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.14 | -3.24 | -4.5 | -2.95 | -0.47 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | -0 | -0 | 0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -234.3 | 30.1 | 20.9 | 28.77 | -20.66 | 50.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.05 | - | 0.08 | - | Upgrade
|
| Asset Writedown | -26.2 | - | - | - | -40.05 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 11.6 | - | Upgrade
|
| Pretax Income | -260.5 | 30.1 | 20.85 | 28.77 | -49.02 | 50.57 | Upgrade
|
| Income Tax Expense | -47.98 | 5.12 | 8.12 | 5.5 | -1.06 | 13.03 | Upgrade
|
| Net Income | -212.52 | 24.98 | 12.73 | 23.27 | -47.97 | 37.55 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Income to Common | -212.52 | 24.98 | 12.73 | 23.27 | -47.97 | 37.55 | Upgrade
|
| Net Income Growth | - | 96.24% | -45.31% | - | - | -8.49% | Upgrade
|
| Shares Outstanding (Basic) | 39 | 39 | 28 | 27 | 19 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 28 | 27 | 19 | 19 | Upgrade
|
| Shares Change (YoY) | 6.31% | 36.37% | 4.65% | 40.14% | - | - | Upgrade
|
| EPS (Basic) | -5.42 | 0.64 | 0.46 | 0.87 | -2.47 | 1.93 | Upgrade
|
| EPS (Diluted) | -5.43 | 0.64 | 0.45 | 0.86 | -2.47 | 1.93 | Upgrade
|
| EPS Growth | - | 42.22% | -47.67% | - | - | -8.53% | Upgrade
|
| Free Cash Flow | 53.41 | 44.51 | -17.79 | 40.14 | 70.65 | 47.87 | Upgrade
|
| Free Cash Flow Per Share | 1.36 | 1.15 | -0.62 | 1.47 | 3.64 | 2.47 | Upgrade
|
| Dividend Per Share | - | - | - | 0.550 | 0.550 | - | Upgrade
|
| Gross Margin | 45.14% | 43.71% | 41.58% | 42.87% | 44.25% | 45.34% | Upgrade
|
| Operating Margin | -39.09% | 7.61% | 6.11% | 7.74% | 5.99% | 13.99% | Upgrade
|
| Profit Margin | -37.73% | 4.37% | 2.32% | 5.02% | -11.98% | 7.53% | Upgrade
|
| Free Cash Flow Margin | 9.48% | 7.79% | -3.25% | 8.66% | 17.64% | 9.60% | Upgrade
|
| EBITDA | -202.26 | 60.64 | 54.14 | 51.17 | 41.48 | 87.13 | Upgrade
|
| EBITDA Margin | -35.90% | 10.61% | 9.88% | 11.04% | 10.36% | 17.46% | Upgrade
|
| D&A For EBITDA | 17.94 | 17.14 | 20.66 | 15.31 | 17.48 | 17.32 | Upgrade
|
| EBIT | -220.2 | 43.5 | 33.48 | 35.86 | 24 | 69.8 | Upgrade
|
| EBIT Margin | -39.09% | 7.61% | 6.11% | 7.74% | 5.99% | 13.99% | Upgrade
|
| Effective Tax Rate | - | 17.02% | 38.95% | 19.10% | - | 25.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.